Department of Radiation Oncology, University of Maryland Medical Center, Baltimore, Maryland.
Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland.
Int J Radiat Oncol Biol Phys. 2019 Jul 15;104(4):756-764. doi: 10.1016/j.ijrobp.2019.03.016. Epub 2019 Mar 15.
To quantify the effects of opening a proton center (PC) on an academic medical center (AMC)/radiation oncology department.
Radiation treatment volume and relative value units from fiscal year 2015 (FY15) to FY17 were retrospectively analyzed at the AMC and 2 community-based centers. To quantify new patient referrals to the AMC, we reviewed the electronic medical record for all patients seen at the PC since consults were initiated in November 2015 (n = 1173). Patients were excluded if the date of entry into the AMC electronic medical record predated their PC consultation. Hospital resource use and professional and technical charges were obtained for these patients. Academic growth, philanthropy, and resident education were evaluated based on grant submissions, clinical trial enrollment, philanthropy, and pediatric case exposure, respectively, from PC opening through FY17.
From FY15 to FY17, radiation fractions at the AMC and the 2 community sites decreased by 14% (95% confidence interval [CI], 12%-16%, P < .001) and increased by 19% (95% CI, 16%-23%, P < .001) and 2% (95% CI, -1.1 to 4.3%, P = NS), respectively; the number of new starts decreased by 3% (95% CI, -13% to 7%, P = NS) and 2% (95% CI, -20% to 16%, P = NS) and increased by 13% (95% CI -2% to 27%, P = NS), respectively. At the AMC, technical and professional relative value units decreased by 5% and 14%, respectively. The PC made 561 external referrals to the AMC, which resulted in $2.38 million technical and $2.13 million professional charges at the AMC. Fifteen grant submissions ($12.83 million) resulted in 6 awards ($3.26 million). Twenty-two clinical trials involving proton therapy were opened, on which a total of 5% (n = 54) of patients enrolled during calendar years 2017 and 2018. The PC was involved in gift donations of $1.6 million. There was a nonsignificant 37% increase in number of pediatric cases.
Despite a slight decline in AMC photon patient volumes and relative value units, a positive downstream effect was associated with the addition of a PC, which benefited the AMC.
量化开设质子中心(PC)对学术医疗中心(AMC)/放射肿瘤学部门的影响。
回顾性分析了 AMC 和 2 家社区中心 2015 财年(FY15)至 FY17 年的放射治疗量和相对价值单位。为了量化向 AMC 转诊的新患者,我们查阅了自 2015 年 11 月咨询开始以来在 PC 就诊的所有患者的电子病历(n=1173)。如果患者进入 AMC 电子病历的日期早于他们的 PC 咨询日期,则将其排除在外。为这些患者获取了医院资源使用情况和专业技术费用。根据 FY17 年 PC 开设以来的拨款申请、临床试验登记、慈善事业和儿科病例暴露情况,评估了学术成长、慈善事业和住院医师教育。
从 FY15 到 FY17,AMC 和 2 个社区站点的放射治疗次数分别减少了 14%(95%置信区间 [CI],12%-16%,P<.001)和增加了 19%(95% CI,16%-23%,P<.001)和 2%(95% CI,-1.1 至 4.3%,P=NS);新患者人数减少了 3%(95% CI,-13%至 7%,P=NS)和 2%(95% CI,-20%至 16%,P=NS),增加了 13%(95% CI,-2%至 27%,P=NS)。在 AMC,技术和专业相对价值单位分别下降了 5%和 14%。PC 向 AMC 转介了 561 例外部转诊患者,这在 AMC 产生了 238 万美元的技术和 213 万美元的专业费用。提交了 15 份赠款申请(1283 万美元),获得了 6 项奖励(326 万美元)。质子治疗的 22 项临床试验已开放,在 2017 年和 2018 年的日历年度中,共有 5%(n=54)的患者入组。PC 参与了 160 万美元的礼品捐赠。儿科病例数增加了 37%,但无统计学意义。
尽管 AMC 光子患者量和相对价值单位略有下降,但随着质子中心的增加,出现了一个积极的下游效应,使 AMC 受益。